FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034222307> ?p ?o ?g. }

• W2034222307 endingPage "423" @default.
• W2034222307 startingPage "422" @default.
• W2034222307 abstract "most common example of this phenomenon is Cushing syndrome due to high endogenous or exogenous cortisol exposure. Iatrogenic Cushing syndrome, characterized by inhibition of statural growth in children, excess weight gain, metabolic syndrome, and hypertension, may be ob-served in CAH patients receiving excessive glucocorti-coid treatment [6] . This is why it is important to balance the need for suppression of adrenal androgen precursors with the opposing practical dictum of minimizing gluco-corticoid exposure, particularly in growing children.One way to achieve the desired balance is to treat clas- sic CAH patients from infancy with a combination of moderate doses of both glucocorticoid and mineralocor-ticoid supplements. A systematic review and meta-analy-sis of treatment outcomes in CAH patients revealed that those children who received long-term treatment with mineralocorticoids achieved significantly better adult heights compared with those who were prescribed gluco-corticoids alone [7] . On the other hand, investigators have observed elevated 24-hour ambulatory blood pres-sure in children [8] and adults [9] with CAH. However, it has not been demonstrated that young adults with CAH suffer clinically significant cardiac morbidities or mortal-ity [10] . Taken together, the implication of the available data is that clinicians should prudently prescribe miner- The study by Mooij et al. [1] in this issue underscores the interrelatedness of adrenal cortical steroids in achiev-ing balance in the treatment of patients with congenital adrenal hyperplasia (CAH). In this set of in vitro experi-ments, the investigators delineate the nature of 17-hy-droxyprogesterone and progesterone interference with the ability of aldosterone to transactivate the mineralo-corticoid receptor (MR). This occurs at the level of recep-tor transactivation, rather than nuclear translocation. It is reasonable to infer from these data that a similar in vivo phenomenon occurs at the high 17-hydroxyprogesterone levels and low physiologic aldosterone levels measured in inadequately controlled classic CAH patients. It has long been recognized that elevated plasma renin levels reflect-ing low aldosterone production and/or activity are found among CAH patients with elevated steroid 21-hydroxy-lase precursors [2, 3] . Previous in vitro studies have con-firmed the hypothesis that progesterone and its analogs are the culprits inhibiting MR [4] . An obvious corollary of these findings is exacerbation of sodium wasting in CAH patients, potentially impeding normal growth and even triggering adrenal crisis. In contrast to the ability of progesterones to interfere with aldosterone-induced MR activity, cortisol may bind to and activate the MR causing hypertension [5] . The" @default.
• W2034222307 created "2016-06-24" @default.
• W2034222307 creator A5042644702 @default.
• W2034222307 date "2015-01-01" @default.
• W2034222307 modified "2023-10-17" @default.
• W2034222307 title "A Rationale for Mineralocorticoid Supplementation in Classic Congenital Adrenal Hyperplasia" @default.
• W2034222307 cites W1972087695 @default.
• W2034222307 cites W1993246152 @default.
• W2034222307 cites W2000429216 @default.
• W2034222307 cites W2017982710 @default.
• W2034222307 cites W2019020433 @default.
• W2034222307 cites W2037836361 @default.
• W2034222307 cites W2076225993 @default.
• W2034222307 cites W2097088751 @default.
• W2034222307 cites W2102643461 @default.
• W2034222307 cites W2129929290 @default.
• W2034222307 cites W2165755939 @default.
• W2034222307 cites W2171651945 @default.
• W2034222307 cites W2325932827 @default.
• W2034222307 cites W2973163287 @default.
• W2034222307 doi "https://doi.org/10.1159/000375531" @default.
• W2034222307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25924649" @default.
• W2034222307 hasPublicationYear "2015" @default.
• W2034222307 type Work @default.
• W2034222307 sameAs 2034222307 @default.
• W2034222307 citedByCount "0" @default.
• W2034222307 crossrefType "journal-article" @default.
• W2034222307 hasAuthorship W2034222307A5042644702 @default.
• W2034222307 hasBestOaLocation W20342223071 @default.
• W2034222307 hasConcept C126322002 @default.
• W2034222307 hasConcept C134018914 @default.
• W2034222307 hasConcept C2776069600 @default.
• W2034222307 hasConcept C2777562237 @default.
• W2034222307 hasConcept C2777767042 @default.
• W2034222307 hasConcept C2778525890 @default.
• W2034222307 hasConcept C71924100 @default.
• W2034222307 hasConceptScore W2034222307C126322002 @default.
• W2034222307 hasConceptScore W2034222307C134018914 @default.
• W2034222307 hasConceptScore W2034222307C2776069600 @default.
• W2034222307 hasConceptScore W2034222307C2777562237 @default.
• W2034222307 hasConceptScore W2034222307C2777767042 @default.
• W2034222307 hasConceptScore W2034222307C2778525890 @default.
• W2034222307 hasConceptScore W2034222307C71924100 @default.
• W2034222307 hasIssue "6" @default.
• W2034222307 hasLocation W20342223071 @default.
• W2034222307 hasLocation W20342223072 @default.
• W2034222307 hasOpenAccess W2034222307 @default.
• W2034222307 hasPrimaryLocation W20342223071 @default.
• W2034222307 hasRelatedWork W1967659878 @default.
• W2034222307 hasRelatedWork W1981633019 @default.
• W2034222307 hasRelatedWork W1986937962 @default.
• W2034222307 hasRelatedWork W2017346924 @default.
• W2034222307 hasRelatedWork W2023418293 @default.
• W2034222307 hasRelatedWork W2037408526 @default.
• W2034222307 hasRelatedWork W2105380188 @default.
• W2034222307 hasRelatedWork W2530319271 @default.
• W2034222307 hasRelatedWork W4232426836 @default.
• W2034222307 hasRelatedWork W4234160658 @default.
• W2034222307 hasVolume "83" @default.
• W2034222307 isParatext "false" @default.
• W2034222307 isRetracted "false" @default.
• W2034222307 magId "2034222307" @default.
• W2034222307 workType "article" @default.